ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 15372 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 15372; 2) Community: the network communities that were significantly associated with the response to NSC 15372; 3) Molecule: the relationships between components within communities and NSC 15372; 4) MDR: the compounds that were significantly associated with the NSC 15372.

NSC Compound Enrichment Correlation
NSC 679001 2-Butenedioic acid, 2-[3-[(ethoxycarbonyl)methyl]-2,4-dioxopyrimidin-1-yl-, diethyl ester, (E)- 0.03551961774939 0.06183923
NSC 681239 Bortezomib 0.03551961774939 -0.0084739463
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.03551961774939 -0.022156965
NSC 683608 Null 0.03551961774939 0.21043395
NSC 687305 4-(N-acetyl-N-ethylamino)isoquinoline-1-carboxaldehyde thiosemicarbazone 0.03551961774939 0.27365318
NSC 691243 Null 0.03551961774939 0.27905998
NSC 691845 Null 0.03551961774939 0.10016145
NSC 696257 2,3-Dihydro-1,2-syn-2-[S-(L)-cysteinylsulfoxide-]-brefeldin A 0.03551961774939 0.17888166
NSC 696558 N-(4-Amino-4-deoxy-N10-methypteroyl)-D,L-homocysteic acid 0.03551961774939 0.23191392
NSC 697166 4H-1,2,4-Triazol-4-amine, 3,3'-(1,8-octanediyl)bis[5-[(4-chlorophenoxy)methyl]- N-phenyl- 0.03551961774939 0.19614978
Total:103  Current:76    [First] [Prev] [Next] [Last]